20-year experience with elderly donors in living renal transplantation

Transplant Proc. 2003 Dec;35(8):2855-7. doi: 10.1016/j.transproceed.2003.10.034.

Abstract

Purpose: This study evaluates the impact of living renal donors (LD) aged 60 years and older on graft performance and patient survival in an old-for-young constellation.

Patients and methods: We analyzed 144 consecutive LDs between January 1983 and December 2002 (19 patients 60+/125 controls).

Results: Mean donor age in the 60+ group was 63.7 (+/- 2.6) years and 43.7 (+/- 9.0) years for the <60 group. Mean recipient age was 42.4 (+/- 15.2) years versus 32.6 (+/- 15.3) years HLA-A, -B, and DR-mismatches were 3.16 (+/- 1.3) for the 60+ group and 3.13 (+/- 1.7) for the controls (P = NS). Rejection episodes in the first year following LD did not differ (53% versus 33%, P =.25). Mean serum creatinine for 65+ versus <65 after 1, 3, and 12 months was 1.91 +/- 1.2 versus 1.48 +/- 0.85 mg/dL (P =.16), 1.82 +/- 0.89 versus 1.29 +/- 0.35 mg/dL (P <.05) and 1.80 +/- 0.31 versus 1.37 +/- 0.38 mg/dL (P <.05) and mean creatinine clearance at 12 months 62 versus 82 mL/min (P =.06). Censored 1-, 3-, and 5-year graft survival was 100% versus 95% (P = NS), 100% versus 93% (P = NS) and 100% versus 83% (P = NS) with no significant difference in the log-rank test for Kaplan Meier.

Conclusion: No impact of donor age was found for graft survival but function of the 65+ kidneys at 3 and 12 months was reduced. Living renal donors 60+ are acceptable for carefully allocated recipients.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Family
  • Female
  • Graft Survival / physiology
  • Histocompatibility Testing
  • Humans
  • Kidney Transplantation / physiology*
  • Living Donors / statistics & numerical data*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome